HCV gp32/gp35/Envelope glycopr
otein E1 Antibody-HCV gp32/gp35/Envelope glycoprotein E1 Antibody- 询价
- Biogradetech
- 美国
- BGT-ANT-35469
- 2025年07月13日
- ELISA,Neutralization
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
免疫原详情见datasheet，该抗体亚型为：IgG1, kappa
- 保存条件：
-2°C-8°C
- 保质期：
1年
- 库存：
100
- 供应商：
艾美捷科技
- 宿主：
Human
- 应用范围：
ELISA,Neutralization
- 抗体英文名：
HCV gp32/gp35/Envelope glycoprotein E1 Antibody
- 抗体名：
HCV gp32/gp35/Envelope glycoprotein E1 Antibody
HCV gp32/gp35/Envelope glycoprotein E1 Antibody，HCV gp32/gp35/Envelope glycoprotein E1 Antibody，HCV gp32/gp35/Envelope glycoprotein E1 Antibody,HCV gp32/gp35/Envelope glycoprotein E1 Antibody
产品名称：HCV gp32/gp35/Envelope glycoprotein E1 Antibody-HCV gp32/gp35/Envelope glycoprotein E1 Antibody
产品货号：BGT-ANT-35469
产品规格：50ug#100ug#1mg
应用类型：ELISA,Neutralization
蛋白别名：gp32, gp35, Envelope glycoprotein E1, Genome polyprotein, Hepatitis C Virus (HCV)
HCV gp32/gp35/Envelope glycoprotein E1 Antibody-HCV gp32/gp35/Envelope glycoprotein E1 Antibody详情见产品datasheet
点击：HCV gp32/gp35/Envelope glycoprotein E1 Antibody-HCV gp32/gp35/Envelope glycoprotein E1 Antibody更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Studying HCV Cell Entry with HCV Pseudoparticles (HCVpp)
HCV infection leads in 50 to 80% of cases to chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma. Interferons and the nucleoside analog ribavirin form the basis for treatment but are not sufficiently effective and have numerous
HCV Genotyping by the Line Probe Assay INNO-LiPA HCV II
which is co- and posttranslationally cleaved into at least nine proteins. Core, E1, and E2 (the structural proteins) and NS2, NS3, NS4A, NS4B, NS5A, and NS5B (the nonstructural [NS] proteins). A theoretical protein of 7 kDa (tp7) may be processed from the carboxy terminal E2 region (1 ).
Detection of Neutralizing Antibodies with HCV Pseudoparticles (HCVpp)
. The presence of a marker gene packaged within these HCV pseudoparticles allows reliable and fast determination of infectivity mediated by the HCV glycoproteins. With this highly flexible system, E1E2 from a broad range of HCV strains can be investigated
技术资料暂无技术资料 索取技术资料
